Dr Hope Rugo: Prescribing Ogivri to Patients
February 8th 2018Hope Rugo, MD, director of the breast oncology clinical trials program at the University of California at San Francisco, discusses the ways in which payers will drive the use of Mylan and Biocon's trastuzumab biosimilar, Ogivri, in patients once it becomes commercially available.
Scott Lassman: The Challenge of Drug Importation
January 31st 2018Scott Lassman, JD, partner in Goodwin's Technology and Life Sciences Group, explains some of the challenges with proposals to allow the United States to import cheaper drugs from Canada or other highly regulated pharmaceutical markets.